Text Size A A

HOME ›   Our Role & Impact

FoxFeed Blog

Latest Blog Posts Tagged "Research News"


Newly Funded Projects: Probing the Protein Parkin

April 16, 2014

Some new projects in the MJFF-funded portfolio focus on learning more about the protein parkin and targeting it with therapies to slow or stop Parkinson's.



Scientists Discover Potential Pathway of LRRK2 Dysfunction

April 14, 2014

Researchers have reported on a potential route through which mutations in the LRRK2 gene — the greatest known genetic contributor to Parkinson's disease (PD) — lead to cell death.



Can Baker's Yeast Help Us Understand Parkinson's Disease?

April 09, 2014

Proteins in baker's yeast may serve a similar purpose as a protein linked with Parkinson's disease.



ABC Rochester Covers Phase III STEADY-PD Study

April 04, 2014

WHAM in Rochester, New York ran a piece on the Phase III study of isradipine happening at the University of Rochester. MJFF funded Phase II.



Coenzyme Q10 Study Shows No Clinical Benefit

April 04, 2014

A recent paper reported that coenzyme Q10, an antioxidant previously showed to slow Parkinson's progression, had no clinical benefit for people with PD.



Measuring Community Activity with Smartphones May Help Track Parkinson's Progression

April 03, 2014

The GPS in smartphones may allow researchers to monitor Parkinson's progression through measure of a patient's Lifespace: the geographical area in which one lives and conducts activities.



23andMe Reports Differences in Parkinson's Disease Symptoms between Men and Women

April 02, 2014

Scott Hadly tells of the latest research from 23andMe's Parkinson's Research Community finding differences in symptom severity in various groups.



Podcast: Drug That May Slow Parkinson's Progression Granted $23 Million from NIH for Phase III Testing

March 31, 2014

Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.



Poor Recruitment Is Top Reason Trials Don't Make It to the Finish Line

March 24, 2014

A recent paper in The Journal of the American Medical Association found that the top reason clinical trials were discontinued was poor participant recruitment.



More Alpha-Synuclein in Spinal Fluid Linked to Faster Cognitive Decline

March 17, 2014

Recently published findings from an MJFF-supported project report that Parkinson's patients with higher levels of the protein alpha-synuclein in spinal fluid experienced faster cognitive decline.


Load more posts






New to MJFF?  Register Now






Forgot username/password?


  Applying for a grant? Sign in here.